Navigation Links
Watchdog to Be Set on Oral Chemotherapy, Warns Experts

A survey conducted by Dana-Farber Cancer Institute in Boston, Massachusetts has come out with findings that oral chemotherapy drugs need to be monitored, prescribed and// coordinated in a better way.

Listing cases of unfortunate events, sourced from the institutes that participated in the research, Dr Lawrence Shulman, of the Dana-Farber Cancer Institute, said findings underline the importance of forging a consensus in the oncology field on standardized safeguards and practices for prescribing and monitoring the use of these drugs.

Many centers had no formal system for monitoring patients taking the drugs, which are becoming increasingly popular internationally.

"Given how quickly oral chemotherapies have become standard care for a growing number of cancers, we were not surprised to find variations in how organizations prescribe and monitor the use of these agents," said Dr Saul Weingart, the president of patient safety at Dana-Farber.

An example was that on prescriptions for the six most common oral chemotherapies: Only 26 percent of the centers required a patient's diagnosis; only 9 percent required a patient's treatment schedule and length of treatment; and only 9 percent required a patient's body surface area calculation, which is used to determine correct and safe drug dose.

The researchers found that almost 70 percent of the centers used handwritten orders for most of the oral chemotherapy prescriptions, 5 percent used preprinted paper prescriptions, and 14 percent used computer-based prescription order entry systems.

Yet another expert thinks that cancer centers need to treat oral chemotherapy drugs in the same way they treat intravenous ones.

"We can't assume that because a drug is an oral drug it is going to be properly prescribed, properly dispensed and properly confirmed that the patient has taken it," said Dr. Len Lichtenfeld, deputy chief medical officer at the American Cancer Societ y. "This study raises the question whether we, as doctors, need to be more vigilant."
ANN
'"/>




Related medicine news :

1. Pets As Disease Watchdogs
2. Health Watchdog Advises a Rethink on NHS Cancer Services
3. Carcinogens in Fish Worries Chinese Watchdogs
4. Drugs Watchdog Faces A Judicial Review
5. Radiation And Chemotherapy, A Better Option For Head And Neck Cancer
6. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
7. Study Warns About The Use Of Popular Asthma Drug To Stop Childrens Coughs
8. ADB Report Warns of Bird-Flu Catastrophe
9. FDA Warns Against Birth-Control Patch
10. Charlotte Church Warns kiss n tell girls not to flirt with Henson
11. UK Committee Warns on Food Shortages Due to Flu Epidemic
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... Plainsboro, NJ (PRWEB) , ... December 08, 2016 , ... ... patients, cancer centers and advocacy groups, has aligned with Upstage Lung Cancer in efforts ... In making the announcement, Michael J. Hennessy, Jr said, “CURE Media Group is honored ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView ... customers and employees that are both engaging and easy to use. Coming off ... the software company revealed today its plans to roll out new AI-powered self-service ...
(Date:12/8/2016)... Dallas, TX (PRWEB) , ... December 08, 2016 , ... ... to continue to be a convenient service for Texas, they are expanding their presence ... will involve a hiring spree that will bring new jobs to the Dallas and ...
(Date:12/8/2016)... ... 2016 , ... Vida Health, the digital health platform that pairs ... Canvas Ventures . Other investors include Nokia Growth Partners (NGP) and returning investor Aspect ... consumers who are managing chronic conditions or simply want to improve their ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... serve communities in and around the greater Phoenix metropolitan region, is announcing a ... , The mission of the Homeless Youth Connection is to promote community awareness ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Dec. 8, 2016  Valeant Pharmaceuticals International, Inc. ... ("Valeant") today announced positive results from a Phase ... assess the safety and efficacy of IDP-118 (halobetasol ... plaque psoriasis. Within the Phase ... to severe psoriasis, IDP-118 showed statistical significance to ...
(Date:12/8/2016)... -- Mederi Therapeutics Inc . hat die behördliche Zulassung durch die ... Refluxerkrankung (GERD) – in China angekündigt. ... ... Live Stretta procedure performed and broadcast during the ... at Wuhan Union Hospital ...
(Date:12/8/2016)...  Boehringer Ingelheim announced today that it has been ... is the ninth time that the company received a ... Place to Work for LGBT Equality. Administered by the ... benchmarking report on corporate policies and practices related to ... employees. "We are committed to creating ...
Breaking Medicine Technology: